Pilatus BiosciencesCancer ImmunotherapyPilatus Biosciences Enters Clinical Collaboration with RochePilatus Biosciences AG, a Swiss biotechnology company headquartered in Epalinges with operations in the United States and South Korea, has entered into a clinical trial collaboration with Roche AG. As … more ➔
adpbe stock photos - David A Litman CancerBayer announces US$1.3bn oncology deal with Kumquat BiosciencesBayer AG’s Pharmaceuticals division in Berlin has expanded its oncology pipeline through a licensing and collaboration agreement with US-based Kumquat Biosciences Inc., which may yield up to US$1.3bn … more ➔
IO BiotechCancer vaccinationIO Biotech’s cancer jab falls short in Phase 3, but Danish firm still eyes FDA approvalIO Biotech has published top-line results from its pivotal Phase 3 trial evaluating the therapeutic cancer vaccine IO102-IO103 (Cylembio) in combination with pembrolizumab in patients with advanced melanoma. … more ➔
lkov - adobe stock photoClinical trialsNovartis’ Ianalumab achieves Phase III endpoint in Sjögren’s syndromeNovartis AG has reported a clinical milestone in the treatment of Sjögren’s syndrome, with its BAFF receptor blocker Ianalumab (VAY736) becoming the first investigational therapy to demonstrate a … more ➔
Dewpoint Therapeutics IncRestructuringDewpoint Therapeutics cuts workforce, refocuses pipelineDewpoint Therapeutics Inc. has announced a significant corporate restructuring. Approximately 70% of its 130 employees will be laid off, and operations will be consolidated at the company’s Boston … more ➔
adobe stock photos - ndomble RegulatoryEU Biotech Act: Have your say!The European Commission has launched a public consultation to support the development of the European Biotech Act, which is now being prioritised after a previous delay. The Commission plans to publish … more ➔
Ragon Institute/MITHIVReiThera starts study on HIV vaccineItalian biotech company ReiThera srl has commenced safety trials of its experimental HIV vaccine candidate, GRAdHIVNE1, in Harare, Zimbabwe. Developed in partnership with the Ragon Institute at Harvard … more ➔
Dr. Edwin P. Ewing, Jr. - http://phil.cdc.gov/phil/home.asp ID#: 70 US Department of Health and Human ServicesDuchenne Muscular DystrophyImlifidase enables gene therapy in Duchenne patients with AAV antibodiesInitial clinical data indicate that the recombinant cysteine protease imlifidase, developed by Hansa Biopharma AB, may significantly reduce levels of anti-AAV antibodies, potentially enabling adeno-associated … more ➔
Daniel Torok, Public domain, via Wikimedia CommonsUS Pharma Prices Trump sets 60-day deadline for US pharma price reductionsUS President Donald Trump has set a deadline in a letter to the CEOs of the 17 leading Big Pharma companies for the announced reduction of prescription drug prices. more ➔
Maxwell Hamilton - wikipedia.orgCOPDGSK licenses COPD blockbuster in US$12bn dealFollowing Merck Sharp & Dohme (MSD)’s US$10bn acquisition of Verona Pharma and its potential COPD blockbuster Ohtuvayre®, GlaxoSmithKline (GSK) has secured a US$12bn deal for another PDE3/PDE4 inhi … more ➔
Pilatus Biosciences
adpbe stock photos - David A Litman 
IO Biotech
lkov - adobe stock photo
Dewpoint Therapeutics Inc
adobe stock photos - ndomble 
Ragon Institute/MIT
Dr. Edwin P. Ewing, Jr. - http://phil.cdc.gov/phil/home.asp ID#: 70 US Department of Health and Human Services
Daniel Torok, Public domain, via Wikimedia Commons
Maxwell Hamilton - wikipedia.org